EW
Edwards Lifesciences Corporation
Stock
$85.15−0.04 (−0.05%)Close Oct 2, 2026
- Net income, 2025
- $1.1B
- YoY, 2025
- −74.3%
- 5-year CAGR
- +5.4%
- 10-year CAGR
- +8.1%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $1.1B | −74.3% |
| 2024 | $4.2B | +197.7% |
| 2023 | $1.4B | −7.9% |
| 2022 | $1.5B | +1.3% |
| 2021 | $1.5B | +82.5% |
| 2020 | $823M | −21.3% |
| 2019 | $1.0B | +45.0% |
| 2018 | $722M | +23.7% |
| 2017 | $584M | +2.5% |
| 2016 | $570M | +15.1% |
| 2015 | $495M | −39.0% |
| 2014 | $811M | +108.5% |
| 2013 | $389M | +33.5% |
| 2012 | $292M | +23.2% |
| 2011 | $237M | +8.6% |
| 2010 | $218M | −4.8% |
| 2009 | $229M | +77.7% |
| 2008 | $129M | — |